Kiryat Tivon, Israel

Keren Francis

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Technion Research & Development Foundation Ltd. Active years: 2014.


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keren Francis: Innovator in Vascularized Islet Technology

Introduction

Keren Francis is a notable inventor based in Kiryat Tivon, Israel. He has made significant contributions to the field of biomedical engineering, particularly in the area of vascularized islets. His work focuses on innovative methods for producing isolated compositions that can enhance medical treatments.

Latest Patents

Keren Francis holds 1 patent for his invention titled "Vascularized islets and methods of producing same." This patent describes an isolated composition of matter that includes a heterogeneous population of cells seeded on a scaffold. The composition comprises at least one pancreatic islet, endothelial cells, and fibroblast cells. The patent also outlines methods for generating this composition and its various uses in medical applications.

Career Highlights

Keren Francis is affiliated with the Technion Research & Development Foundation Ltd., where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment of diabetes and other related conditions.

Collaborations

Keren collaborates with Shulamit Levenberg, a fellow researcher who contributes to the development of his innovative projects. Their partnership exemplifies the importance of teamwork in advancing scientific research.

Conclusion

Keren Francis is a pioneering inventor whose work in vascularized islets represents a significant advancement in biomedical engineering. His contributions are poised to make a lasting impact on medical treatments and patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…